STUDIO

SPERMOSENS PRESENTATION

BioStock Investor Pitch: Spermosens

Swedish Spermosens’ vision is to improve diagnostics within the area of male infertility and thus help improve IVF treatments. Using the company’s JUNO-Checked system...
Alligator

Alligator Bioscience presents positive interim data

Cyxone's CEO on the current state and the pipeline

Cyxone’s CEO on the current state and the pipeline

WntResearch om den uppdaterade studieplanen för NeoFox-studien

WntResearch on the revised study plan for the NeoFox-study

Spago Nanomedical's CDO on the endometriosis study

Spago Nanomedical’s CDO on the endometriosis study

Load more

RECOMMENDED READING

RhoVac acquires Chosa Oncology

RhoVac becomes Chosa Oncology after acquisition

After last year´s disappointing phase IIb-readout, a lot has happened for Lund based biotech...
SynAct

SynAct Pharma’s acquisition of TXP Pharma concluded

Just before the end of 2022, SynAct Pharma announced its plans to acquire the...
Lipum

Lipum’s clinical development journey continues in 2023

Iconovo

Iconovo starts 2023 with negotiations for ICOpre

SPERMOSENS PRESENTATION

BioStock Investor Pitch: Spermosens

Sarah Lidé

VILDA – new network for female leaders in life science

EVENT

© BioStock 2023